2016, Number S2
Clinical features of patients with influenza-like illness who went to a third level center in the winter of 2013-2014
PDF size: 309.67 Kb.
ABSTRACTBackground: between October 2013 and April 2014, the Centers for Disease Control and Prevention reported a high incidence of AH1N1 influenza cases. Not all suspicious cases of influenza are confirmed; however, all patients need treatment and generate additional costs to the institutions. Our objective was to describe the characteristics of the patients treated for influenza suspicion at Hospital de Especialidades in Centro Médico Nacional Siglo XXI during a new epidemic.
Methods: Cross-sectional study of all cases admitted at the Emergency Service (of the aforementioned hospital) for influenza-like illness, defined according to current guidelines. Based on these guidelines, we analyzed the risk factors that may have increased the severity of the infection.
Results: We registered a total of 109 patients with a mean age of 44 years, 78 % were under 60 years of age, 62 % were women, 75 % had at least one comorbidity, such as obesity (26 %) or hypertension (27 %). Only 65 patients had results from a confirmatory test, 33.8 % had positive diagnosis, and 21 % of them eventually died.
Conclusions: The frequency of confirmed cases for influenza infection is low. The risk factors associated with complications and increased mortality are hypertension, leukocytosis and clinical presentation of severe acute respiratory syndrome.
Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infectious Dis. 2012;12(9):687-95.
Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129-40.
Fedson DS. Meeting the challenge of influenza pandemic preparedness in developing countries. Emerging Infectious Diseases. 2009;15(3):365-71.
Ebell MH, Afonso AM, Gonzales R, Stein J, Genton B, Senn N. Development and validation of a clinical decision rule for the diagnosis of influenza. J Am Board Fam Med. 2012;25(1):55-62.
Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infectious Dis. 2007;7(10):658-66.
Arriola CS, Brammer L, Epperson S, Blanton L, Kniss K, Mustaquim D, et al. Update: influenza activity - United States, September 29, 2013-February 8, 2014. Morb Mortal Wkly Rep. 2014;63(1):48-54.
Neri-Salvador J, Barranco-Garduño L, León-Molina H, Tovar-Serrano A, Rendón-Macías M, Flores-Murrieta F. Factores predictores de defunción en pacientes con neumonía por influenza a H1n1. Med Int Mex. 2011;27(5):421-8.
Instituto Mexicano del Seguro Social (IMSS). Prevención, Diagnóstico y Tratamiento de la Influenza A(H1N1). México: IMSS; 2009. Disponible en http://www.imss.gob.mx/sites/all/statics/ guiasclinicas/000GER_H1N1.pdf
Abdelaty NM. Risk factors and prognostic criteria in 230 patients with influenza A (H1N1) infection. Egypt J Chest Dis Tuberc. 2013;62(1):1-8.
Sugerman D, Nadeau KH, Lafond K, Cameron W, Soetebier K, Jhung M, et al. A survey of emergency department 2009 pandemic influenza A (H1N1) surge preparedness--Atlanta, Georgia, July-October 2009. Clin Infect Dis. 2011;52(Suppl 1):S177-82.
Chretien JP, George D, Shaman J, Chitale RA, McKenzie FE. Influenza forecasting in human populations: a scoping review. PLoS One. 2014;9(4):e94130.
Doshi P. Trends in recorded influenza mortality: United States, 1900-2004. Am J Public Health. 2008;98(5):939-45. doi: 10.2105/AJPH.2007.119933.
Davila J, Chowell G, Borja-Aburto VH, Viboud C, Grajales-Muñiz C, Miller M. Substantial Morbidity and Mortality Associated with Pandemic A/H1N1 Influenza in Mexico, Winter 2013-2014: Gradual Age Shift and Severity. PLoS Curr. 2014 March 26; 6: ecurrents.outbreaks. a855a92f19db1d90ca955f5e908d6631. Published online 2014 March 26. doi: 10.1371/currents. outbreaks.a855a92f19db1d90ca955f5e908d6631
Bansal S, Pourbohloul B, Hupert N, Grenfell B, Meyers LA. The shifting demographic landscape of pandemic influenza. PLoS One. 2010 Feb 26;5(2):e9360. doi: 10.1371/journal.pone.0009360.
Trejo-Valdivia B, Mendoza-Alvarado LR, Palma-Coca O, Hernández-Ávila M, Téllez-Rojo Solís MM. Encuesta Nacional de Cobertura de Vacunación (influenza, neumococo y tétanos) en Adultos Mayores de 60 años en México. Salud Publica Mex. 2012;54(1):39- 46. Consultado el 16 de febrero de 2016. Disponible en http://www.redalyc.org/pdf/106/10623032006.pdf
Godlee J. Predicting and preparing for pandemic flu. BMJ. 2009;339:b2988.
Centers for Disease Control and Prevention (CDC). Rapid Diagnostic Testing for Influenza: Information for Clinical Laboratory Directors. Last updated: October 13, 2015. Disponible en http://www.cdc.gov/flu/ professionals/diagnosis/rapidlab.htm
Sanchez JF, Ghamande SA, Midturi JK, Arroliga AC. Invasive diagnostic strategies in immunosuppressed patients with acute respiratory distress syndrome. Clin Chest Med. 2014 Dec;35(4):697-712. doi: 10.1016/j.ccm.2014.08.008.
Wu UI, Wang JT, Ho YC, Pan SC, Chen YC, Chang SC. Factors associated with development of complications among adults with influenza: a 3-year prospective analysis. J Formos Med Assoc. 2012;111(7):364-9. doi: 10.1016/j.jfma.2011.04.005.
Lee N, Choi KW, Chan PK, Hui DS, Lui GC, Wong BC, et al. Outcomes of adults hospitalised with severe influenza. Thorax. 2010 Jun;65(6):510-5. doi: 10.1136/thx.2009.130799.
Rorat M, Jurek T, Kuchar E, Szenborn L. The clinical course of late diagnosed fatal cases of A (H1N1) influenza in Poland. Postepy Hig Med Dosw (Online). 2013 Jun 20;67:595-600. doi: 10.5604/17322693.1053910.